RxDoctor Payments Data

Mari Tassarotti, MD

Vascular & Interventional Radiology · Boston, MANPI 1376063578

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.4%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medtronic at 31.4% of the total. Reporting peaked in 2024 at $4,352 and has fallen 75.8% since, to $1,052 in 2025.

$10,688in general payments, 2019–2025

Across 90 payments — averaging $118.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Penumbra, Inc.$3K
  • Boston Scientific$1K
  • Argon Medical Devices, Inc.$779
  • Trisalus Life Sciences, Inc.$768
  • Cook Medical LLC$486
  • plus $1K from 4 others
$44,057in research payments, 2019–2025

Across 3 payments — averaging $14,686 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Instylla, Inc.$44K

What the payments were for

  • Grants$2,60124%
  • Travel & lodging$2,69525%
  • Food & beverage$5,28349%
  • Education$1091%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,688 in reported general payments places this provider in the 75th percentile of 89 vascular & interventional radiology providers in Massachusetts.

See all vascular & interventional radiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$54,838
Medicare patients
129
Services billed
360

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →